Երկիր: Ավստրալիա
Լեզու: անգլերեն
Աղբյուրը: Department of Health (Therapeutic Goods Administration)
Icodextrin; Sodium chloride; Magnesium chloride; Calcium chloride; Sodium lactate
Baxter Healthcare Pty Ltd
Medicine Registered
PRODUCT INFORMATION CONSUMER MEDICINE INFORMATION EXTRANEAL (ICODEXTRIN 7.5%) BLOOD GLUCOSE MANAGEMENT WITH EXTRANEAL MUST BE DONE WITH A GLUCOSE-SPECIFIC METHOD TO AVOID INTERFERENCE RESULTING IN UNRECOGNISED HYPOGLYCEMIA. IF NON- SPECIFIC GLUCOSE TEST METHODS (GDH-PQQ) ARE USED, LOSS OF CONSCIOUSNESS, NEUROLOGICAL DAMAGE AND DEATH MAY OCCUR. WHAT IS IN THIS LEAFLET THIS LEAFLET ANSWERS SOME MORE COMMON QUESTIONS ABOUT EXTRANEAL. IT DOES NOT CONTAIN ALL OF THE AVAILABLE INFORMATION. All medicines have risks and benefits. Your doctor has weighed the risks of you taking Extraneal against the benefit they expect it will have for you. It does not take the place of talking to your Doctor. If you have any concerns about taking the medicine, ask your doctor or Renal nurse. Keep this leaflet with the medicine, as you may need to read it again. WHAT EXTRANEAL IS USED FOR Extraneal is used as a replacement for a single glucose exchange (e.g. Dianeal product), as part of a Continuous Ambulatory Peritoneal Dialysis (CAPD) or Automated Peritoneal Dialysis (APD) regimen for chronic renal failure. BEFORE THE USE OF EXTRANEAL FORMULA DO NOT USE EXTRANEAL IF: You have a known allergy to any of the ingredients listed at the end of this leaflet or to starch. You have a glycogen storage disease. Additionally tell your Doctor if you have recently had surgery on your stomach or if you have any other stomach complaints. PRECAUTIONS: Blood glucose measurement must be done with a glucose-specific method to prevent maltose interference with test results. Since falsely elevated glucose levels have been observed with blood glucose monitoring devices and test strips that use glucose dehydrogenase pyrroloquinolinequinone (GDH PQQ)-based methods, GDH PQQ-based m Կարդացեք ամբողջական փաստաթուղթը
Extraneal Product Information Extraneal PI _30 June 2011 Page 1 of 17 Baxter EXTRANEAL BLOOD GLUCOSE MANAGEMENT WITH EXTRANEAL MUST BE DONE WITH A GLUCOSE-SPECIFIC METHOD TO AVOID INTERFERENCE RESULTING IN UNRECOGNISED HYPOGLYCEMIA. IF NON- SPECIFIC GLUCOSE TEST METHODS GLUCOSE DEHYDROGENASE PYRROLOQUINOLINEQUINONE (GDH-PQQ) , GLUCOSE-DYE-OXIDOREDUCTASE (GDO) OR GLUCOSE DEHYDROGENASE FLAVIN- ADENINE DINUCLEOTIDE (GDH-FAD)) -BASED METHODS ARE USED, LOSS OF CONSCIOUSNESS, NEUROLOGICAL DAMAGE AND DEATH MAY OCCUR (SEE WARNING/PRECAUTIONS). (I) NAME OF THE MEDICINE : EXTRANEAL (Icodextrin 7.5%) Peritoneal Dialysis Solution (II) DESCRIPTION : EXTRANEAL is a sterile peritoneal dialysis fluid containing Icodextrin as the active ingredient at a concentration of 7.5% w/v in an electrolyte solution. It is presented in a flexible PVC bag and is sterile, non-pyrogenic and contains no bacteriostatic or antimicrobial agents or added buffers. Each 1000mL of EXTRANEAL contains : Icodextrin 75 g Sodium Chloride 5.4g Sodium Lactate 4.5g Calcium Chloride 257mg Magnesium Chloride 51mg Sodium Hydroxide pH adjustment Hydrochloric acid pH adjustment Water for injections q.s. Theoretical Osmolarity 284 (milliosmoles per litre) Electrolyte Solution Content per 1000mL: Sodium 133 mmol Calcium 1.75 mmol Magnesium 0.25 mmol Chloride 96 mmol Lactate 40 mmol Extraneal Product Information Extraneal PI _30 June 2011 Page 2 of 17 Baxter Icodextrin is an α (1-4) linked glucose polymer which contains 5-10% α (1-6) links. It is produced by the hydrolysis of starch and fractionated by membrane separation technology to produce material with the desired molecular weight distribution Կարդացեք ամբողջական փաստաթուղթը